Here are relevant reports on : veterinary-regenerative-medicine-market
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Europe Artificial Intelligence (AI) in Healthcare Market by Offering (Integrated), Function (Diagnosis, Genomic, Precision Medicine, Radiation, Telehealth, RPM, Immunotherapy, Supply Chain), Application (Clinical), End User (Hospitals) - Forecast to 2030
The Europe artificial intelligence (AI) in healthcare market is projected to reach USD 31.72 billion by 2030 from USD 6.12 billion in 2025, at a CAGR of 39.0% during the forecast period. The prominent players operating in the Europe artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), and Amazon Web Services, Inc. (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the Europe artificial intelligence (AI) in healthcare market.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Human Organoids Market by Product (Liver, Kidney, Pancreatic Models (2D, 3D)), Disease Area (Oncology, GI, Neurological Disorders), Application (Drug Toxicity, Personalized Medicine), End User (Pharma & Biotech Companies, CROs) - Global Forecast to 2029
The global human organoids market, valued at US$1.07 billion in 2023, stood at US$1.19 billion in 2024 and is projected to advance at a resilient CAGR of 14.4% from 2024 to 2029, culminating in a forecasted valuation of US$2.33 billion by the end of the period. The main factor driving this market is the rising demand for organoids in drug testing, as they provide more reliable results than conventional 2D cell cultures.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
U.S. Veterinary Infusion Pumps Market by Type (Large Volume Infusion Pumps, Syringe Infusion Pumps), End User (Private Hospitals, Private Clinics, Teaching Hospitals) - Global Forecast to 2021
The U.S. veterinary infusion pumps market is expected to witness growth in the coming years as a result of the growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels. This market is projected to reach USD 35.4 Million by 2021 from USD 26.6 Million in 2016, at a CAGR of 5.8% from 2016 to 2021. Growing adoption of companion animals and increasing prevalence of animal diseases requiring surgeries are the major factors that are expected to offer potential growth opportunities to market players. However, increasing pet care costs may hinder the growth of this market to a certain extent.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Veterinary Orthopedics Market by Product (Instruments, Implants), Application (Total Knee Replacement, Total Hip Replacement, Total Elbow Replacement), Animal Type (Companion, Livestock), End User (Hospitals, Clinics) - Global Forecast to 2027
The global veterinary orthopedics market is projected to reach USD 823.9 million by 2027 from USD 545.3 million in 2022, at a CAGR of 8.4% during the forecast period. Market is driven by factors such as growth in companion animal population, growing demand for pet insurance, and rising expenditure on animal healthcare. On the other hand, high cost of veterinary orthopedic devices and procedure is expected to restrain market growth to a some extent during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Veterinary Surgical Procedures Market by Surgery Type (Spaying/Neutering, Dental, Soft Tissue, Orthopedic, Ophthalmic, Neurosurgery), Animal Type (Small Animals & Large Animals), End User (Hospitals, Clinics, Laboratory) - Global Forecast to 2029
The global veterinary surgical procedures market, valued at US$45.4 billion in 2023, stood at US$48.3 billion in 2024 and is projected to advance at a resilient CAGR of 7.0% from 2024 to 2029, culminating in a forecasted valuation of US$67.8 billion by the end of the period. Development of new surgical instruments, robotics, and imaging technologies like 3D printing and VR training for vets, improves efficiency and success rates of procedures which is expected to drive the growth of the market.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Veterinary Surgical Instruments Market by Product (Sutures, Foreceps, Scissors, Electrosurgery Instruments, Cannulas), Animal (Canines, Felines, Large Animals), Application (Soft tissue, Sterilization, Gynecology, Orthopedic Surgery)- Global Forecast to 2021
The global veterinary surgical instruments market size is projected to grow at a CAGR of 6.6%. The increasing demand for veterinary surgical instruments is driven by the rising companion animal population coupled with the growing demand for pet insurance, the rising animal health awareness levels along with the increasing animal healthcare expenditure.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Veterinary Dermatology Market by Route of Administration, Product type (Antibacterial, Antifungal, Antiparasitic Drugs, Monoclonal Antibodies), Condition type (Parasitic Infections, Infectious Diseases, Skin Cancer), Animal type - Global Forecast to 2030
Global veterinary dermatology market valued at $18.59B in 2024, reached $20.11B in 2025, and is projected to grow at a robust 8.5% CAGR, hitting $ 30.31B by 2030. The major factors that are driving the market are expanding companion animal population and pet ownership, growing concerns about infectious zoonotic diseases, rising awareness initiatives by government and animal welfare organizations, and increased adoption of pet insurance and high animal healthcare expenditure.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030
The global veterinary infectious disease diagnostics market, valued at US$2.66 billion in 2024, stood at US$2.87 billion in 2025 and is projected to advance at a resilient CAGR of 8.0% from 2025 to 2030, culminating in a forecasted valuation of US$4.22 billion by the end of the period.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Monoclonal Antibodies Market by Animal Type (Canine, Feline, Swine), Product (Cytopoint, Librela, Solensia), Therapy Area (Dermatology, Infectious, Osteoarthritis, Pain, Oncology, Others), Route of Administration - Global Forecast to 2030
The global veterinary monoclonal antibodies market, valued at US$1.52 billion in 2024, stood at US$1.70 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2025 to 2030, culminating in a forecasted valuation of US$3.06 billion by the end of the period. Opportunities in the market involve expanding therapeutic uses beyond dermatology and osteoarthritis, as well as developing new administration routes for monoclonal antibodies.
- Published: September 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
